Clinical trial
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin…
NCT00068042 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00068042 |
|---|---|
| Title | A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly |
| Official title | A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acromegaly |
| Intervention type | Drug |
| Interventions | Pegvisomant, Sandostatin LAR |
| Enrollment | 100 |
| Start date | Apr 1, 2003 |
| Completion | May 1, 2006 |
| First posted | Sep 8, 2003 |
| Last update posted | Apr 7, 2008 |
| Countries | Australia, Brazil, Canada, France, Germany, Greece, Ireland, Italy, Norway, Spain, Sweden, United Kingdom and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: